Reversal of hypopigmentation in phenylketonuria mice by adenovirus- mediated gene transfer

Pediatric Research

Volumn 45, Issue 4 I, 1999, Pages 465-473

  Nagasaki, Yutaka ^a   Matsubara, Yoichi ^a   Takano, Hideaki ^a   Fujii, Kunihiro ^a   Senoo, Masato ^a   Akanuma, Jun ^a   Takahashi, Kazutoshi ^a   Kure, Shigeo ^a   Hara, Masahiro ^a   Kanegae, Yumi ^b   Saito, Izumu ^b   Narisawa, Kuniaki ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; TACROLIMUS;

AMINO ACID BLOOD LEVEL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HYPOPIGMENTATION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LIVER FUNCTION TEST; MENTAL DEFICIENCY; MOUSE; NONHUMAN; PHENYLKETONURIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS DRUG ADMINISTRATION; WESTERN BLOTTING;

EID: 0032939161     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199904010-00003     Document Type: Article

References (38)

1. Lidsky AS, Law ML, Morse HG, Kao FT, Rabin M, Ruddle FH, Woo SLC 1985 Regional mapping of the phenylalanine hydroxylase gene and the phenylketonuria locus in the human genome. Proc Natl Acad Sci USA 82:6221-6225
2. Scriver CR, Kaufman S, Eisensmith RC, Woo SLC 1995 The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Basis of Inherited Disease. McGraw-Hill, New York, pp 1015-1075
3. Rezvani I, Auerbach VH 1987 Defects in metabolism of amino acids. In: Behrman RE, Vaughan VC (eds) Nelson Textbook of Pediatrics. Saunders, Philadelphia, pp 280-305
4. Newbold PCH 1973 The skin in genetically-controlled metabolic disorders. J Med Genet 10:101-111
5. Liu TJ, Kay MA, Darlington GJ, Woo SLC 1992 Reconstitution of enzymatic activity in hepatocytes of phenylalanine hydroxylase-deficient mice. Somat Cell Mol Genet 18:89-96
6. Shedlovsky A, McDonald JD, Symula D, Dove WF 1993 Mouse models of human phenylketonuria. Genetics 134:1205-1210
7. Fang B, Eisensmith RC, Li XHC, Finegold MJ, Shedlovsky A, Dove W, Woo SLC 1994 Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Ther 1:247-254
8. McDonald JD, Charlton CK 1997 Characterization of mutations at the mouse phenylalanine hydroxylase locus. Genomics 39:402-405
9. Niwa H, Yamamura K, Miyazaki J 1991 Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-200
10. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I 1996 Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus. Proc Natl Acad Sci U S A 93:1320-1324
11. Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S, Saito I 1995 Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res 23:3816-3821
12. Saito I, Oya Y, Yamamoto K, Yuasa T, Shimojo H 1985 Construction of nondefective adenovirus type 5 bearing a 2:8-kilobase hepatitis B virus DNA near the right end of its genome. J Virol 54:711-719
13. Kanegae Y, Makimura M, Saito I 1994 A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47:157-166
14. Naruse H, Ohashi, YY, Tsuji A, Maeda M, Nakamura K, Fujii T, Yamaguchi A, Matsumoto M, Shihata M 1992 A method of PKU screening using phenylalanine dehydrogenase and microplate system. Screening 1:63-66
15. Bartholome K, Lutz P, Bickel H 1975 Determination of phenylalanine hydroxylase activity in patients with phenylketonuria and hyperphenylalamnemia. Pediatr Res 9:899-903
16. ash mice and in OTC-deficient human hepatocytes with recombinam adenoviruses bearing the CAG promoter. Hum Gene Ther 7:821-830
17. Bickel H, Gerrard J, Hickmans EM 1954 Influence of phenylalanine intake on the chemistry and behaviours of a phenylketonuric child. Acta Paediatr 43:64-73
18. Eisensmith RC, Woo SLC 1995 Molecular genetics of phenylketonuria: from molecular anthropology to gene therapy. Adv Genet 32:199-271
19. Eisensmith RC, Woo SLC 1996 Somatic gene therapy for phenylketonuria and other hepatic deficiencies. J Inherit Metab Dis 19:412-423
20. Miyamoto M, Fitzpatrick TB 1957 Competitive inhibition of mammalian tyrosinase by phenylalanine and its relationship to hair pigmentation in phenylketonuria. Nature 179:199-200
21. Farishian RA, Whittaker JR 1980 Phenylalanine lowers melanin synthesis in mammalian melanocytes by reducing tyrosine uptake: implications for pigment reduction in phenylketonuria. J Invest Dermatol 74:85-89
22. Coskun T, Özalp I, Kale G, Gögus S 1990 Scleroderma-like skin lesions in two patients with phenylketonuria. Eur J Pediatr 150:109-110
23. Huard J, Lochmüller H, Acsadi G, Jani A, Massie B, Karpati G 1995 The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 2:107-115
24. Kass-Eisler A, Falck-Pedersen E, Elfenbein DH, Alvira M, Buttrick PM, Leinwand LA 1994 The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther 1:395-402
25. Yang Y, Nunes FA, Berencsi K, Furth EE, Gönczöl E, Wilson JM 1994 Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A 91:4407-4411
26. Yang Y, Trinchieri G, Wilson JM 1995 Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat Med 1:890-893
27. Kay MA, Holterman AX, Meuse L, Gown A, Ochs HD, Linsley PS, Wilson CB 1995 Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat Genet 11:191-197
28. Fang B, Eisensmith RC, Wang H, Kay MA, Cross RE, Landen CN, Gordon G, Bellinger DA, Read MS, Hu PC, Brinkhous KM, Woo SLC 1995 Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum Gene Ther 6:1039-1044
29. Smith TAG, White BD, Gardner JM, Kaleko M, McClelland A 1996 Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. Gene Ther 3:496-502
30. Lochmüller H, Petrof BJ, Pari G, Larochelle N, Dodelet V, Wang Q, Allen C, Prescott S, Massie B, Nalbantoglu J, Karpati G 1996 Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene Ther 3:706-716
31. Vilquin JT, Guérette B, Kinoshita I, Roy B, Goulet M, Gravel C, Roy R, Tremblay JP 1995 FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum Gene Ther 6:1391-1401
32. Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okuhara M, Kohsaka M, Aoki H, Ochiai T 1987 FK-506, a novel immunosuppressant isolated from a Streptomyces, II: immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 40:1256-1265
33. Lagodzinski Z, Gorski A, Wasik M 1990 Effect of FK506 and cyclosporine on primary and secondary skin allograft survival in mice. Immunology 71:148-150
34. Wang Q, Greenburg G, Bunch D, Farson D, Finer MH 1997 Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector. Gene Ther 4:393-400
35. Clemens PR, Kochanek S, Sunada Y, Chan S, Chen HH, Campbell KP, Caskey CT 1996 In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther 3:965-972
36. Hommes FA, Moss L 1992 Myelin turnover in hyperphenylalaninaemia: a reevaluation with the HPH-5 mouse. J Inherit Metab Dis 15:243-251
37. Hommes FA 1994 Loss of neurotransmitter receptors by hyperphenylalaninemia in the HPH-5 mouse brain. Acta Paediatr Suppl 407:120-121
38. Diamond A, Ciaramitaro V, Donner E, Djali S, Robinson MB 1994 An animal model of early-treated PKU. J Neurosci 14:3072-3082